Qualcomm Incorporated (NASDAQ: QCOM), a leading developer and innovator of advanced wireless technologies, products and services, today announced that it will showcase some of the latest innovations and ideas that are enabling access, control and interaction with the digital world during the GSMA Mobile World Congress 2011 (Booth 8B53, Hall 8), Feb. 14-17 in Barcelona. The Company’s demonstrations will feature next-generation mobile technologies and services designed to drive today’s and the future’s most advanced mobile devices and experiences. Highlights of the exhibit include LTE Advanced, HSPA+ Advanced, augmented reality, devices based on the Snapdragon™ mobile computing platform, WiPower™ and the Internet of Everything Module (IEM) design for enabling the “Internet of Everything.”
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/qualcomm/48665/
Bob Evans Farms, Inc. (NASDAQ: BOBE), is proud to announce its commitment to support America’s active duty, veterans, and their families with the launch of its “Our Farm Salutes” campaign. As part of the program, Bob Evans Farms has painted its iconic barn purple, a color that represents every branch of service, and is donating $200,000 as well as thousands of meals to support the Gary Sinise Foundation’s (GSF) Serving Heroes program, an initiative that provides meals to active duty, veterans, and their families as a way of showing gratitude for their service and sacrifice.
“Supporting the men and women that serve our country has always been a part of the culture at Bob Evans Farms, and we could not be more excited to further our commitment of showing gratitude by encouraging others to join us as we salute all of those that unselfishly serve us,” said Bob Evans Farms, Inc. President and CEO Saed Mohseni. “In painting the Bob Evans barn purple and partnering with the Gary Sinise Foundation in support of their Serving Heroes program, we are making it known that ‘Our Farm Salutes’ all of America’s active duty, veterans, and their families.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7865851-bob-evans-our-farm-salutes/
OpenText™ (NASDAQ: OTEX, TSX: OTC), the global leader in Enterprise Information Management (EIM), today unveiled OpenText Web Experience Management (WEM), an innovative solution to help organizations exceed their customers’ online expectations by providing a targeted, responsive experience across omni-channel touch points, multiple languages and devices with varied capabilities and form-factors.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/61775-opentext-web-experience-management-engage-your-web-traffic
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today celebrates 10 years of the availability and success of its NovaSure endometrial ablation system. Since 2001, more than one and a half million women have been treated with the NovaSure system to reduce or eliminate their heavy periods, without the need to undergo hysterectomy. The NovaSure procedure is a one-time, five-minute procedure that can be performed in the doctor’s office with very minimal recovery time.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/hologic/50096/
National Instruments (Nasdaq: NATI) today announced the new NI cRIO-9068 software-designed controller, which is completely redesigned but maintains full NI LabVIEW and I/O compatibility with the CompactRIO platform. The controller integrates state-of-the-art technologies including the Xilinx Zynq-7020 All Programmable system on a chip (SoC), which combines a dual-core ARM® Cortex™-A9 processor and Xilinx 7 Series FPGA fabric.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62759-national-instruments-redesigns-ni-compactrio-software-controller-platform
National Instruments (Nasdaq: NATI) today introduced a 14 GHz version of its NI PXIe-5665 high-performance RF vector signal analyzer (VSA), which delivers best-in-class dynamic range and accuracy in a cost-effective PXI form factor. The new VSA features industry-leading phase noise and dynamic range, regardless of form factor, including traditional rack-and-stack instruments. Because of its PXI platform, the VSA can deliver measurement speeds up to 20 times faster than box instruments and for less cost. Additionally, it takes advantage of multicore computing architectures and parallel programming capabilities through NI LabVIEW system design software. It also offers peer-to-peer data streaming for signal processing and a flexible multiple input, multiple output (MIMO) architecture for phase-coherent measurements. Such features make it ideal for demanding RF test applications including radio detection and ranging (RADAR), satellite, radio and harmonic testing.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/nationalinstruments/51200/
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today the launch of the WebMD Pregnancy app, a free iPhone® app offering expectant moms WebMD’s physician-reviewed pregnancy information that is customizable to fit a woman’s unique pregnancy. The WebMD Pregnancy App is WebMD’s latest addition to its multi-screen platform approach which provides actionable health information when consumers want it most, enabling them to better manage their health. WebMD is the leader in mobile for health information, with WebMD’s mobile apps for consumers having been downloaded over 16 million times.1
To view Multimedia News Release, go to http://www.multivu.com/mnr/60045-webmd-launches-new-pregnancy-app-for-iphone
1appFigures data through December 26, 2012; includes WebMD App, WebMD Baby App, WebMD Pain Coach App
WebMD Health Corp. (Nasdaq: WBMD), the leading source of health information, announced today its new WebMD Allergy app for the iPhone, an innovative new mobile resource that empowers consumers to take control of their allergies. It is the first free app to provide allergy sufferers with personalized location-based allergy condition forecasts in combination with WebMD’s trusted information and insights. WebMD Allergy is further personalized with optional mobile push notifications that warn when allergen levels are high, enabling app users to proactively manage their allergy conditions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60044-webmd-introduces-new-allergy-app-for-iphone
Nutrisystem, Inc. (NASDAQ: NTRI), the number one home delivery weight loss company, announced today that it is revamping its programs by incorporating its highest scoring, best tasting fresh frozen gourmet foods into all of its weight loss plans at the lowest price in the Company’s history. Part of Nutrisystem’s “Hooray You! New You Revolution” initiative is to empower and celebrate the success of its members, and with these significant changes it will make Nutrisystem® weight loss programs more accessible to a wider audience than ever before.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/nutrisystem/47901/
ViaSat Inc. (NASDAQ: VSAT) has announced that International Launch Services has successfully launched ViaSat-1, the highest capacity satellite in the world. The Proton M launch vehicle lifted off from pad 39 at the Baikonur Cosmodrome, Kazakhstan, at 11:48 am (PDT) October 19, followed by spacecraft separation from the launch vehicle at 9:12 pm, signal acquisition shortly thereafter, and finally deployment of both the north and south solar arrays.
To view Multimedia News Release, go to http://www.multivu.com/players/English/47671-viasat-satellite-launch/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced The New England Journal of Medicine has published results from the North American Phase 3 trial evaluating the safety and efficacy of the Company’s novel antibiotic fidaxomicin as a treatment for patients with Clostridium difficile infection (CDI). The Phase 3 trial showed that fidaxomicin significantly reduced recurrence rates and increased global cure rates when compared to vancomycin, the only treatment approved by the U.S. Food and Drug Administration for CDI. The article titled,
